CEPS Technology - Peptiligase Selection & Engineering
We are very happy that we managed another time hosting Enzytag as a speaker for our webinar, presenting how peptiligases are selected and engineered to achieve highest efficacy in the synthesis of specific linear and cyclic peptide drugs and drug conjugates.
Bachem has unique capabilities in the area of solid phase, hybrid, and solution phase peptide chemistry of therapeutic peptides. We are passionate about innovation with a strong focus on realizing value in all areas of the company. As we are convinced that Enzytag’s innovative technology offers substantial advantages regarding efficiency, and towards greener manufacturing, we are proud to host them for this webinar.
Expand your knowledge about the peptiligases and their optimization possibilities in this webinar presented by Dr. Leendert van den Bos, the Co-Founder at Enzytag. Interested?
If you missed our first webinar with Enzytag, please watch our YouTube webinar record to learn about the basics of their “Chemo Enzymatic Peptide Synthesis” or “CEPS”: • Chemo Enzymatic Ligation
------------------------------------------------------------------------------------------------
About Bachem:
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see www.bachem.com.
Learn more about our products and services at https://www.bachem.com/
Bachem. Leading Partner in Tides